title: Citalopram.
abstract: Citalopram is a selective serotonin (5-HT) reuptake inhibitor (SSRI) developed by H. Lundbeck A/S in Denmark. It is the most selective serotonin antidepressant with proven efficacy, a favourable pharmacokinetic profile and a low potential for interactions with other concomitant medication. The drug has a low incidence of side effects, even when compared to the other SSRIs and good patient compliance and satisfaction is a feature of this drug. These factors make the drug a good choice for depressed patients who require continuation and long-term treatment, as well as for elderly patients. Copyright 2000 John Wiley & Sons, Ltd.
authors.affiliation: Lundbeck Institute, Grevinde Danners Palæ, Skodsborg strandvej 113, DK 2942 Skodsburg, Denmark.
authors.forename: Andre F.
authors.initials: AF
authors.lastname: Joubert
authors.forename: Connie
authors.initials: C
authors.lastname: Sánchez
authors.forename: Frank
authors.initials: F
authors.lastname: Larsen